Filing Details
- Accession Number:
- 0001181431-13-063458
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-18 18:59:48
- Reporting Period:
- 2013-12-16
- Filing Date:
- 2013-12-18
- Accepted Time:
- 2013-12-18 18:59:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1392380 | Gevo Inc. | GEVO | Industrial Organic Chemicals (2860) | 870747704 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1083218 | Ganesh Kishore | Gevo, Inc., 345 Inverness Drive South Building C, Suite 310 Englewood CO 80112 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-16 | 37,037 | $0.00 | 89,295 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2013-12-16 | 370,370 | $0.00 | 2,041,795 | No | 4 | P | Indirect | See foonote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | See foonote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrant (right to buy) | Acquisiton | 2013-12-16 | 37,037 | $0.00 | 37,037 | $1.85 |
| Common Stock | Common Stock Warrant (right-to-buy) | Acquisiton | 2013-12-16 | 370,370 | $0.00 | 370,370 | $1.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 37,037 | 2013-12-16 | 2018-12-16 | No | 4 | P | Direct |
| 370,370 | 2013-12-16 | 2018-12-16 | No | 4 | P | Indirect |
Footnotes
- The shares of common stock and the warrants to purchase common stock were purchased together as common stock units, but were issued separately. Each common stock unit consisted of one share of common stock and a warrant to purchase one share of common stock, at a public offering price of $1.35 per common stock unit. Each warrant has an exercise price of $1.85 per share (subject to adjustment in certain circumstances), became exercisable on the date of original issuance and will expire on December 16, 2018.
- The reporting person is deemed to be the beneficial owner of shares held by Malaysian Life Sciences Capital Fund Ltd. as previously reported on the Form 4 filed February 15, 2011.
Billionaire Hedge Funds
